EEG Entropy in REM Sleep as a Physiologic Biomarker in Early Clinical Stages of Alzheimer’s Disease
Journal of Alzheimer's Disease · 14.02.2023 · 91 (4) · 1557-1572
DOI: 10.3233/jad-221152 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, erschienen am 14.02.2023. Verfasst von Hamed Azami und 6 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts Alzheimer's Disease Research Center, Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Dementia, Cognitive Dysfunction. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Background
Alzheimer’s disease (AD) is associated with EEG changes across the sleep-wake cycle. As the brain is a non-linear system, non-linear EEG features across behavioral states may provide an informative physiologic biomarker of AD. Multiscale fluctuation dispersion entropy (MFDE) provides a sensitive non-linear measure of EEG information content across a range of biologically relevant time-scales.
Objective
To evaluate MFDE in awake and sleep EEGs as a potential biomarker for AD.
Methods
We analyzed overnight scalp EEGs from 35 cognitively normal healthy controls, 23 participants with mild cognitive impairment (MCI), and 19 participants with mild dementia due to AD. We examined measures of entropy in wake and sleep states, including a slow-to-fast-activity ratio of entropy (SFAR-entropy). We compared SFAR-entropy to linear EEG measures including a slow-to-fast-activity ratio of power spectral density (SFAR-PSD) and relative alpha power, as well as to cognitive function.
Results
SFAR-entropy differentiated dementia from MCI and controls. This effect was greatest in REM sleep, a state associated with high cholinergic activity. Differentiation was evident in the whole brain EEG and was most prominent in temporal and occipital regions. Five minutes of REM sleep was sufficient to distinguish dementia from MCI and controls. Higher SFAR-entropy during REM sleep was associated with worse performance on the Montreal Cognitive Assessment. Classifiers based on REM sleep SFAR-entropy distinguished dementia from MCI and controls with high accuracy, and outperformed classifiers based on SFAR-PSD and relative alpha power.
Conclusion
SFAR-entropy measured in REM sleep robustly discriminates dementia in AD from MCI and healthy controls.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Massachusetts Alzheimer's Disease Research Center, Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA.
- Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.
- Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.
Förderung
- NINDS NIH HHS
- NIA NIH HHS
Zitieren
APA
Azami, H., Moguilner, S., Penagos, H., Sarkis, R. A., Arnold, S. E., Gomperts, S. N., & Lam, A. D. (2023). EEG Entropy in REM Sleep as a Physiologic Biomarker in Early Clinical Stages of Alzheimer’s Disease. Journal of Alzheimer's Disease, 91(4), 1557-1572. https://doi.org/10.3233/jad-221152
Vancouver
Azami H, Moguilner S, Penagos H, Sarkis RA, Arnold SE, Gomperts SN, et al. EEG Entropy in REM Sleep as a Physiologic Biomarker in Early Clinical Stages of Alzheimer’s Disease. Journal of Alzheimer's Disease. 2023;91(4):1557-1572. doi:10.3233/jad-221152
BibTeX
@article{Azami2023,
author = {Azami, Hamed and Moguilner, Sebastian and Penagos, Hector and Sarkis, Rani A and Arnold, Steven E and Gomperts, Stephen N and Lam, Alice D},
title = {EEG Entropy in REM Sleep as a Physiologic Biomarker in Early Clinical Stages of Alzheimer’s Disease},
journal = {Journal of Alzheimer's Disease},
year = {2023},
volume = {91},
number = {4},
pages = {1557--1572},
doi = {10.3233/jad-221152}
}
EUVIMED